We are live on ! Find out more
INM icon

InMed Pharmaceuticals
INM

9 hedge funds and large institutions have $206K invested in InMed Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $
Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$44.3K
2
+$18.8K
3
+$17.6K
4
SM
Sabby Management
Florida
+$17.6K
5
UBS Group
UBS Group
Switzerland
+$7.25K

Top Sellers

1
-$13.5K
2
-$12.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$142K
Citadel Advisors
2
Citadel Advisors
Florida
$30.3K
VF
3
Virtu Financial
New York
$13K
TSS
4
Two Sigma Securities
New York
$12.1K
UBS Group
5
UBS Group
Switzerland
$5.2K
PWMG
6
Private Wealth Management Group
New Jersey
$3.23K
SS
7
SBI Securities
Japan
$193
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
–
Jane Street
10
Jane Street
New York
–